Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Not applicable Interventional

Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS)

ClinicalTrials.gov ID: NCT03900468

Public ClinicalTrials.gov record NCT03900468. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 3:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT03900468
Recruitment status
Terminated
Study type
Interventional
Phase
Not applicable
Lead sponsor
MedtronicNeuro
Industry
Enrollment
29 participants

Conditions and interventions

Conditions

Interventions

  • Activa™ PC and Percept™ PC Neurostimulation Systems Device

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 4, 2020
Primary completion
Oct 14, 2025
Completion
Feb 25, 2026
Last update posted
Apr 23, 2026

2020 – 2026

United States locations

U.S. sites
7
U.S. states
5
U.S. cities
7
Facility City State ZIP Site status
University of California Los Angeles (UCLA) Los Angeles California 90095-1406
University of California San Francisco UCSF Medical Center San Francisco California 94143
Emory University Hospital Atlanta Georgia 30303-3049
University of Kansas Medical Center Kansas City Kansas 66160-8500
Mayo Clinic (Rochester MN) Rochester Minnesota 55905
Cleveland Clinic Cleveland Ohio 44195
The Ohio State University Columbus Ohio 43210

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03900468, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2026 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03900468 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →